|
|
|
Insider
Information: |
Landau Jeffrey B |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
110,060 |
|
Indirect Shares
|
7,680 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
117,740 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-03-19 |
110,060 |
2024-03-19 |
7,680 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business OfficerOfficer |
|
2022-03-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,680 |
|
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
|
2023-03-16 |
4 |
S |
$1.98 |
$2,923 |
D/D |
(1,477) |
69,248 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2023-12-20 |
4 |
S |
$1.38 |
$5,628 |
D/D |
(4,077) |
86,622 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2023-09-22 |
4 |
S |
$1.30 |
$5,356 |
D/D |
(4,119) |
76,379 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2022-07-20 |
4 |
S |
$1.42 |
$5,982 |
D/D |
(4,206) |
30,725 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2024-03-19 |
4 |
S |
$2.09 |
$13,685 |
D/D |
(6,562) |
110,060 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2022-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
34,931 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2023-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
80,498 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2023-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
90,699 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
116,622 |
0 |
- |
|
CTMX |
Cytomx Therapeutics, Inc. |
Chief Business Officer |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
70,725 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|